glyoxylate reductase/hydroxypyruvate reductase
| GO Term | Evidence Code | PMID |
|---|---|---|
| dicarboxylic acid metabolic process | ||
| dicarboxylic acid metabolic process | ||
| glyoxylate metabolic process | ||
| glyoxylate metabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm | ||
| cytoplasm | ||
| cytosol | ||
| catalytic complex | ||
| catalytic complex |
| GO Term | Evidence Code | PMID |
|---|---|---|
| glycerate dehydrogenase activity | ||
| glycerate dehydrogenase activity | ||
| glycerate dehydrogenase activity | ||
| hydroxypyruvate reductase activity | ||
| glyoxylate reductase (NADP+) activity |
| Gene Ontology |
|---|
| oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| oxidoreductase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111671 | primary hyperoxaluria type 2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025